[LABU] Direxion Daily S&P Biotech Bull 3X ETF

Overview

Type of security: Fund

Tags:

The data is delayed by 15 minutes.

 

Price: 35.36 Change: 3.46 (10.85%)
Ext. hours: 35.36 Change: 0 (0%)

chart LABU

Refresh chart

Strongest Trends Summary For LABU

LABU is in the medium-term up 79% in 3 weeks and down -52% in 4 months and down -40% below S&P in 7 months. In the long-term down -91% below S&P in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Technical Data
High 52 week114.68 Low 52 week25.13 Last close45.58 Last change0.97%
RSI61.83 Average true range4.48 Beta4.49 Volume3.12 M
Simple moving average 20 days25.52% Simple moving average 50 days3.27% Simple moving average 200 days-41.78%
Performance Data
Performance Week33.35% Performance Month3.48% Performance Quart-38.88% Performance Half-57.71%
Performance Year-41.85% Performance Year-to-date38.71% Volatility daily9.01% Volatility weekly20.15%
Volatility monthly41.3% Volatility yearly143.06% Relative Volume194.91% Average Volume4.53 M
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio Total net assets
Weighted market capitalization

News

2019-01-14 10:05:37 | This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders

2019-01-10 16:39:01 | Big Biopharma Mergers Could Fuel These ETFs in 2019

2018-11-08 10:47:06 | Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat

2018-11-06 10:36:53 | After a Rough October, Leveraged Biotech ETF Looks to Bounce Back

2018-09-27 11:58:30 | 5 Leveraged ETFs for Active Traders

2018-08-31 09:12:41 | How the Biotech Sector Has Fared this Year

2018-07-18 12:27:43 | Exploring The Leveraged ETF Trade Heading Into Earnings Season

2018-07-12 15:51:46 | Pharma, Biotech Bull ETFs Leading the Charge

2018-06-22 12:56:43 | 5 Big Direxion ETFs Trending This Week

2018-06-05 09:04:34 | Biotech Sector Continue to Dazzle Despite Market Distress

2018-04-10 13:47:03 | Catalysts Abound for Biotech ETFs

2018-02-07 08:35:00 | Biotech Stocks Trade Near Major Levels of Support

2018-02-05 11:59:34 | Healthcare Dip Could be a Buying Opportunity

2018-01-31 10:18:03 | 5 Best-Performing Leveraged ETFs of January

2017-12-29 09:09:02 | The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC

2017-11-29 16:46:23 | Short Interest And Leveraged ETFs

2017-11-29 14:06:34 | CUREs For The Ordinary December Trade

2017-11-14 15:49:03 | Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate

2017-11-05 14:43:00 | Top 3 Performing ETFs in 2017

2017-10-20 15:16:37 | Starting Small Offers Some Protection With Opportunities

2017-09-15 15:26:33 | Biotech, Pharma ETFs Leave Pricing Drama Behind

2017-09-08 10:31:42 | Biotech ETF Investing is Hot, Can Get Hotter

2017-09-01 10:49:32 | Biotech ETFs Remain Bell of the Ball

2017-08-31 16:37:34 | A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers

2017-08-30 10:53:17 | Biotech ETF Investing is Starting to Look Good – Here’s Why

2017-07-27 14:43:02 | 4 Things To Know Before Trading A Leveraged ETF

2017-07-03 09:30:01 | The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs?ls Bull 3X ETF and Direxion Daily MSCI India Bull 3

2017-06-30 14:40:26 | Cure The Summer Doldrums With Leveraged Biotech ETFs

2017-06-30 11:41:03 | Best Leveraged ETFs of First Half of 2017

2017-06-23 14:43:03 | Too Late To Catch Biotech Rally As Trump Fears Subside?

2017-05-18 13:08:58 | Are Stock Returns during Summer Months That Bad?

2017-04-04 09:02:56 | Healthcare Moves Have Been Muted, but Could We Get a Surprise?

2017-03-17 10:47:32 | Biotech company may have a cure for the cancer that killed Apple’s Steve Jobs

2017-02-17 13:40:00 | Biotech 2017: 4 Ideas for A Stockpicker's Year

2017-01-31 17:09:10 | Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting

2017-01-31 13:08:06 | Biotech Stocks Gain on Latest Trump Drug Price Statements

2017-01-11 12:31:00 | Stocks Recover But Pharma Still Down After Trump's Threats

2017-01-04 10:56:00 | Trying to Knock Out Some Individual Trades, but it Is not Easy

2016-12-08 10:34:26 | How Will Trump’s Take on the ACA Affect Healthcare Stocks?

2016-11-15 10:47:03 | 6 Leveraged ETFs Soaring on Trump Rally

2016-11-11 15:16:53 | Biotech ETFs Unwind Political Risk After Trump Victory

2016-11-08 09:34:54 | Which Sectors to Invest in If Donald Trump Wins

2016-11-01 11:20:00 | Biotech Stocks Rise As Most Other Sectors Fall

2016-10-21 09:54:29 | Five Biotech ETFs Posting Strong Second-Halfs: From ALPS Medical Breakthroughs SBIO To The SPDR S&P Biotech ETF XBI

2016-10-14 15:26:44 | Can Biotech Stocks Stay “Trendy”?

2016-10-14 11:43:40 | Seize ETF Tools To Position Your Portfolio For Any Election Outcome

2016-10-04 00:15:00 | Best and Worst Performing ETFs of Q3 2016 SOXL, LABU

2016-10-03 10:58:02 | 5 Best Performing Leveraged ETFs of September

2016-09-27 15:21:50 | Loving LABU: A Leveraged Biotech ETF On A Torrid Pace

2016-08-25 06:52:48 | The Active Traders Guide To Hillary Clinton's Rhetoric

LABU motifs

There is no motif for this symbol